ANNA OWEN: Open Payments
NPI 1972283695 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$647 in 30 payments from 14 companies in 2025. Trend: 2023 $20 · 2024 $19 · 2025 $647
Food & beverage: $647
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $158 |
| PFIZER INC. | 4 | $88 |
| Corcept Therapeutics | 3 | $60 |
| Dexcom, Inc. | 3 | $57 |
| Lilly USA, LLC | 2 | $41 |
| Amgen Inc. | 2 | $37 |
| Novo Nordisk Inc | 2 | $34 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
Products named: UBRELVY, Korlym, Dexcom G6 Transmitter, NURTEC ODT, PREVNAR 20, MOUNJARO, QULIPTA, EVENITY.
Industry payments across ID — which companies pay providers there.
